Sjögren’s syndrome
Teresa Tarrant, MD
Duke University
Durham, North Carolina, United States
Disclosure(s): Amgen: Grant/Research Support (Ongoing); Chiesi: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing), Grant/Research Support (Ongoing); Department of Justice: Consultant (Ongoing); X4 Pharmaceuticals: Consultant (Ongoing), Grant/Research Support (Ongoing)
Blake M. Warner, PhD, DDS, MPH
National Institutes of Health
Bethesda, Maryland, United States
Disclosure(s): Astellas: Grant/Research Support (Ongoing); Pfizer: Grant/Research Support (Ongoing)
Sjögren's syndrome is a systemic autoimmune disease with glandular and extra-glandular immune and epithelial dysregulation. The goal of this session is to explore aberrant molecular and cellular disease pathogenesis at the cytokine and cellular level with emphasis on T cell and epithelial biology.
Speaker: Mohammad Haj Dezfulian, PhD – Harvard Medical School
Speaker: Sarthak Gupta, MD – NIAMS, NIH
Speaker: Gwenny Verstappen, PhD, PharmD – University Medical Center Groningen